Paper Maker Oji Ventures into Pharma Biz with Wood-Derived Drugs, Eyes Clinical Trial by 2023

August 4, 2020
Japanese paper manufacturing powerhouse Oji Holdings said on August 3 that it has set up a new subsidiary for the development and commercialization of pharmaceutical products based on a wood-derived compound, aiming to bring them into the clinic by 2023...read more